Skip to main content

The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formation

Buy Article:

$43.00 plus tax (Refund Policy)

Hovden A-O, Sommerfelt MA. The influence of CD4 and CXCR4 on maedi-visna virus-induced syncytium formation. APMIS 2002;110:697–708.

CD4 is the principal binding site for human and simian immunodeficiency virus (HIV/SIV) receptor interactions and the α chemokine receptor CXCR4 has been implicated as a primordial lentivirus receptor. This study sought to determine the relevance of CD4 and CXCR4 in virus-receptor interactions for the prototype lentivirus, maedi-visna virus (MVV) of sheep. Neither CD4 nor α/β chemokine receptors represent principal receptors for MVV since human osteosarcoma cells devoid of these molecules were susceptible to productive infection. Interestingly, the presence of either CD4 and/or CXCR4 on indicator cells dramatically enhanced MVV-induced cell fusion (syncytium formation) for three independent virus strains. Syncytium formation results from virus-receptor interactions and can be inhibited by receptor ligands. However, neither SDF-1α that binds CXCR4 nor recombinant gp120 (rgp120) that binds CD4 could specifically inhibit the observed enhancement of MVV-induced cell fusion under conditions that significantly reduced HIV-1-induced cell fusion. Our observations suggest that CD4 and CXCR4 may represent optional auxiliary components of an MVV receptor (or receptor complex) that facilitate MVV-mediated membrane fusion events, a feature important for virus entry. This potential accessory role for CXCR4 in MVV receptor interactions may reflect the distant relationship between the ovine (MVV) and the human/feline lentiviruses (HIV/FIV).
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: CD4; CXCR4; Syncytia; maedi-visna virus

Document Type: Research Article

Affiliations: Department of Molecular Biology and

Publication date: 2002-10-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more